{
	"section-title": "Expert Opinion",
	"section-id": "expert-opinion",
	"section-description": "Opinions and insights from key opinion leaders and the front lines of care.",
	"items": [
		{
			"id": "0001",
			"featured": true,
			"type": "Journal Scan: Research",
			"section": "Story of the week",
			"pub-date": {
				"date": {
					"year": "2012", "month": "March", "day": "19"},
				"time":{
					"hour": "2012", "minute": "March"}
			},
			"practice-relevance" : 3,
			"title": "New Induction Standard for Acute Myeloid Leukemia",
			"url": "",
			"source": {
				"type": "expert",
				"name": {
					"firstName": "Lee", "middleName": "S.", "lastName": "Schwartzberg", "honorific": "MD, FACP"},
				"position": {
				"title":"placeholder"},
				"photo": {
					"url":"content/img/users/Bonnie_Cunningham_2009_REVI_tcm8-199718.jpg"}
			},
			"item-content": {
				"take-home-message": "<p>In a phase III trial of patients with acute myeloid leukemia, adding cladribine, but not fludarabine, to induction with daunorubicin/cytarabine significantly increased overall survival and can be considered a new standard of care.</p>",
				"referenced-item": {
					"featured": true,
					"type": "commentary",
					"section": "commentary",
					"title": "Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study",
					"source": {
						"type": "journal",
						"journal":{
							"title": "Journal of Clinical Oncology",
							"url": "",
							"img": "content/img/journal/jco.gif",
							"pub-date": {
								"date": {
									"year": "2012", "month": "March", "day": "19"}
								}
							}
						}
					}
				}
		},
		{
			"id": "0002",
			"featured": false,
			"type": "commentary",
			"pub-date": {
				"date": {
					"year": "2012", "month": "March", "day": "19"},
				"time":{
					"hour": "2012", "minute": "March"}
			},
			"practice-relevance" : 2,
			"section": "commentary",
			"title": "PCI-32765 Is One of the Most Exciting Drugs Around",
			"url": "",
			"source": {
				"type": "expert",
				"name": {
					"firstName": "Susan", "middleName": "M.", "lastName": "O'Brien", "honorific": "MD"},
				"position": {
				"title": "placeholder"},
				"photo": {
					"url": "http://oncologystat.com/Images/susan_obrien_tcm8-277885.jpg"
				},
				"citation": "Clin Cancer Res. 2012 Mar 29;[Epub Ahead of Print], DN Finegold, CJ Baty, KZ Knickelbein, S Perschke, SE Noon, D Campbell, JM Karlsson, D Huang, MA Kimak, EC Lawrence, E Feingold, SD Meriney, AM Brufsky, RE Ferrell"
			},
			"item-content": {
				"item-teaser": "In this interview, Dr. O&#8217;Brien discusses the highly successful results of studies evaluating PCI-32765, a novel Bruton&#8217;s tyrosine kinase (BTK) inhibitor, in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)."
			}
		},
		{
			"featured": false,
			"type": "Ask the Expert",
			"section": "Ask the Expert",
			"pub-date": {
				"date": {
					"year": "2012", "month": "January", "day": "30"},
				"time":{
					"hour": "2012", "minute": "March"}
			},
			"practice-relevance" : 1,
			"title": "Ask the Expert: Should I Use Adjuvant Therapy in DCIS?",
			"url": "",
			"source": {
				"type": "expert",
				"name": {
					"firstName": "Patrick", "middleName": "W.", "lastName": "Cobb", "honorific": "MD, FACP"},
				"position": {
				"title":"placeholder"},
				"photo": {
					"url":"content/img/users/clifford_hudis_tcm8-5788.jpg"}
			},
			"item-content": {
			}
		},
		{
			"id": "0003",
			"featured": false,
			"type": "Cancer Policy Forum",
			"section": "Cancer Policy Forum",
			"pub-date": {
				"date": {
					"year": "2012", "month": "March", "day": "14"},
				"time":{
					"hour": "2012", "minute": "March"}
			},
			"practice-relevance" : 3,
			"title": "How to Fix Cancer Drug Shortages",
			"url": "",
			"source": {
				"type": "expert",
				"name": {
					"firstName": "Clifford", "middleName": "", "lastName": "Hudis", "honorific": "MD"},
				"position": {
				"title":"placeholder"},
				"photo": {
					"url":"content/img/section/CancerPolicyForum_143x90_tcm8-243574.jpg"}
			},
			"item-content": {
			}
		},
		{
			"id": "0004",
			"featured": false,
			"type": "Cancer Policy Forum",
			"section": "Cancer Policy Forum",
			"pub-date": {
				"date": {
					"year": "2012", "month": "March", "day": "14"},
				"time":{
					"hour": "2012", "minute": "March"}
			},
			"practice-relevance" : 3,
			"title": "How to Fix Cancer Drug Shortages",
			"url": "",
			"source": {
				"type": "expert",
				"name": {
					"firstName": "Clifford", "middleName": "", "lastName": "Hudis", "honorific": "MD"},
				"position": {
				"title":"placeholder"},
				"photo": {
					"url":"content/img/section/CancerPolicyForum_143x90_tcm8-243574.jpg"}
			},
			"item-content": {
			}
		}
	]
}